| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/27/2014 | US20140056809 Treatment and diagnosis of macrophage mediated disease |
| 02/26/2014 | EP2700652A1 Diagnosis and treatment of cancer using anti-itm2a antibody |
| 02/26/2014 | EP2700412A1 PROBIOTICS, SECRETORY IgA AND INFLAMMATION |
| 02/26/2014 | EP2700411A1 Probiotics, secretory IgA and infection |
| 02/26/2014 | EP2700410A1 Neutralizing monoclonal antibodies against the Nogo-66 receptor (NGR) and uses thereof |
| 02/26/2014 | EP2700409A1 IL-27 for modulation of immune response in acute lung disease |
| 02/26/2014 | EP2699688A1 Regimens and compositions for aav-mediated passive immunization of airborne pathogens |
| 02/26/2014 | EP2699682A2 Novel hypoallergens |
| 02/26/2014 | EP2699681A1 Hypoallergen |
| 02/26/2014 | EP2699602A2 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
| 02/26/2014 | EP2699601A1 Antibody polypeptides that antagonize cd40 |
| 02/26/2014 | EP2699599A2 Gpr177 as target and marker in tumors |
| 02/26/2014 | EP2699598A2 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer |
| 02/26/2014 | EP2699597A1 Modified variable domain molecules and methods for producing and using them b |
| 02/26/2014 | EP2699587A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof |
| 02/26/2014 | EP2699318A1 Vaccine delivery method |
| 02/26/2014 | EP2699266A1 Compositions and methods for stabilization of active agents |
| 02/26/2014 | EP2699264A1 Antibodies and other molecules that bind b7-h1 and pd-1 |
| 02/26/2014 | EP2699263A2 Methods for reducing an adverse immune response to a foreign antigen in a human subject with anti-cd4 antibodies or cd4-binding fragments thereof or cd4-binding molecules |
| 02/26/2014 | EP2699262A2 Bispecific antibodies against her2 and cd3 |
| 02/26/2014 | EP2699261A1 Method for treating osteoporosis |
| 02/26/2014 | EP2699260A1 Bispecifc antibodies against her2 |
| 02/26/2014 | EP2699259A1 Bcma-based stratification and therapy for multiple myeloma patients |
| 02/26/2014 | EP2699258A2 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 02/26/2014 | EP2699257A1 Peptide and conjugate vaccines for fungal infections |
| 02/26/2014 | EP2699256A1 Compositions and methods for the treatment of neuromyelitis optica |
| 02/26/2014 | EP2699255A1 Process for preparing vaccine composition |
| 02/26/2014 | CN103608464A Clostridium difficile antigens |
| 02/26/2014 | CN103608352A Method for producing protein preparation |
| 02/26/2014 | CN103608071A Formulation for anti-alpha4beta7 antibody |
| 02/26/2014 | CN103608041A An aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 02/26/2014 | CN103608040A Antibodies and other molecules that bind B7-H1 and PD-1 |
| 02/26/2014 | CN103608039A BCMA-based stratification and therapy for multiple myeloma patients |
| 02/26/2014 | CN103608038A Methods of administering beta7 integrin antagonists |
| 02/26/2014 | CN103608037A Use of anti-DKK1 monoclonal antibody for treatment of liver cancer |
| 02/26/2014 | CN103608036A Vaccine adjuvant composition comprising inulin particles |
| 02/26/2014 | CN103608035A Immunomodulatory methods and systems for treatment and/or prevention of hypertension |
| 02/26/2014 | CN103608034A Process for preparing vaccine composition |
| 02/26/2014 | CN103608033A Individualized vaccines for cancer |
| 02/26/2014 | CN103608032A Method for suppressing an immune response |
| 02/26/2014 | CN103608031A Method for treating IFNalpha related conditions |
| 02/26/2014 | CN103608030A Compositions and methods for therapy and diagnosis of cancer |
| 02/26/2014 | CN103608028A Human myeloid derived suppressor cell cancer markers |
| 02/26/2014 | CN103602689A Development of dengue virus vaccine components |
| 02/26/2014 | CN103602639A Method of harvesting viruses by low-osmotic-pressure harvest liquid |
| 02/26/2014 | CN103602638A Recombinant equine influenza virus strain, preparation method thereof and vaccine prepared from recombinant equine influenza virus strain |
| 02/26/2014 | CN103602629A Methods for culturing swine testis cell in serum-free manner and producing classical swine fever cell vaccine by using swine testis cell |
| 02/26/2014 | CN103601809A HCV multi-epitope peptide, truncated NS3, and DC activating molecule EDA recombinant protein vaccine and applications thereof |
| 02/26/2014 | CN103601806A Il-6结合分子 Il-6 binding molecules |
| 02/26/2014 | CN103599541A Compositions and methods for the prevention of oxidative degradation of proteins |
| 02/26/2014 | CN103599535A External ointment prepared from i26 immune egg powder and traditional Chinese medicine decoction |
| 02/26/2014 | CN103599534A Preparation method and use of poultry vaccine-specific pig spleen transfer factor |
| 02/26/2014 | CN103599533A Chicken new castle disease-infectious bronchitis trivalent combined vaccine and preparation method thereof |
| 02/26/2014 | CN103599532A Chicken infectious bronchitis divalent live vaccine and preparation method thereof |
| 02/26/2014 | CN103599531A Chicken infectious bronchitis live vaccine, heat-resisting protective agent and preparation method of the vaccine |
| 02/26/2014 | CN103599530A Method for preparation of rubella attenuated live vaccine by serum-free culture medium |
| 02/26/2014 | CN103599529A 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition |
| 02/26/2014 | CN103599528A Method for preparing human dendritic cell vaccine |
| 02/26/2014 | CN103599130A Preparation method of anti-neweastle disease virus specific transfer factor and oral liquid, and use thereof |
| 02/26/2014 | CN103599076A High-activity poultry antibody effervescent granular preparation and preparation method thereof |
| 02/26/2014 | CN103599071A Preparation method of polyinosinic-polycytidylic acid dry powder |
| 02/26/2014 | CN102772792B Vaccine for preventing decayed tooth and preparation method thereof |
| 02/26/2014 | CN102746381B Helicobacter pylori antigen HLA restrictive immunodominance epitope peptide and preparation method and application thereof |
| 02/26/2014 | CN102617731B Porcine circovirus-resistant type 2 egg yolk antibody, and preparation method and application thereof |
| 02/26/2014 | CN102432695B Preparation method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan carried Newcastle disease attenuated live vaccine-loaded nanoparticles |
| 02/26/2014 | CN102370977B Novel vaccine adjuvant and application |
| 02/26/2014 | CN102329809B Reverse genetic operating system of canine distemper virus (CDV)/R-20/8 vaccine strain and application thereof |
| 02/26/2014 | CN102321635B Preparation method for human papillomaviral empty capsid particles, and products thereof |
| 02/26/2014 | CN102311972B Method for preparing Porcine circovirus type 2 antigen with chloroplast and its product |
| 02/26/2014 | CN102093477B Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 02/26/2014 | CN102028940B Edwardsiella tarda surface display type vaccine and preparation and application thereof |
| 02/26/2014 | CN101657213B A method for enhancing t cell response |
| 02/26/2014 | CN101003573B Human antibodies that bind human tnfalpha |
| 02/25/2014 | US8658771 Humanized antibodies against human interferon-alpha |
| 02/25/2014 | US8658767 Lipidated polyepitope vaccines |
| 02/25/2014 | US8658766 Soluble hybrid Fcγ receptors and related methods |
| 02/25/2014 | US8658610 Replication-competent anti-cancer vectors |
| 02/25/2014 | US8658607 Immunostimulatory G, U-containing oligoribonucleotides |
| 02/25/2014 | US8658592 Biologically active peptides and their new uses |
| 02/25/2014 | US8658433 Dye compounds as photoactive agents |
| 02/25/2014 | US8658386 Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis |
| 02/25/2014 | US8658380 Diagnostic and therapeutic target |
| 02/25/2014 | US8658180 Vaccines against influenza virus |
| 02/25/2014 | US8658179 Glycosylated specificity exchangers |
| 02/25/2014 | US8658178 Carbon nanotube compositions and methods of use thereof |
| 02/25/2014 | US8658177 Promiscuous HER-2/Neu CD4 T cell epitopes |
| 02/25/2014 | US8658176 Lipidated tumor-associated antigens and immunotherapeutic compositions |
| 02/25/2014 | US8658175 Anti-EGFR antibodies and their uses |
| 02/25/2014 | US8658174 GLP/1/exendin 4 IgG Fc fusion constructs for treatment of diabetes |
| 02/25/2014 | US8658173 Anti-mesothelin antibodies |
| 02/25/2014 | US8658172 Treatment of metastatic breast cancer |
| 02/25/2014 | US8658170 Combination therapy with MDM2 and EFGR inhibitors |
| 02/25/2014 | US8658169 Antibodies against IL-25 |
| 02/25/2014 | US8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells |
| 02/25/2014 | US8658167 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 02/25/2014 | US8658166 Methods and materials for the diagnosis of prostate cancers |
| 02/25/2014 | US8658165 Method of treating aberrant mucus production in respiratory disease |
| 02/25/2014 | US8658164 Methods and materials for the diagnosis of prostate cancers |
| 02/25/2014 | US8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 02/25/2014 | US8658136 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response |